Levitra ODT - a new era in the treatment of erectile dysfunction

Vertkin A.L.

Moskovskiĭ gosudarstvennyĭ mediko-stomatologicheskiĭ universitet

Morgunov L.Iu.

Moskovskiĭ gosudarstvennyĭ mediko-stomatologicheskiĭ universitet

Levitra ODT - a new era in the treatment of erectile dysfunction

Authors:

Vertkin A.L., Morgunov L.Iu.

More about the authors

Journal: Problems of Endocrinology. 2013;59(1): 57‑61

Downloaded: 11

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Vertkin AL, Morgunov LIu. Levitra ODT - a new era in the treatment of erectile dysfunction. Problems of Endocrinology. 2013;59(1):57‑61. (In Russ.)

Close metadata

Recommended articles:

Diagnosis and treatment of erectile dysfunction in patients with type 1 diabetes mellitus. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2024;(3):5-10

Efficacy and safety of topical antibiotic therapy in patients with acute external bacterial otitis: results of a retrospective study. Russian Bulletin of Otorhinolaryngology. 2024;(6):24-27

Open observational study with a retrospective analysis of the efficacy and tolerability of aceclofenac in patients with acute non-specific low back pain. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):99-105

On the issue of choosing anesthesia methods: a comparison of general medicine and clinical dentistry. Stomatology. 2025;(1):76-80

Efficacy and safety of fonturacetam in asthenia: a systematic review and meta-analysis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):69-79

Erectile dysfincion is a complicated pathology having negative influence on the man's self-esteem, the quality of sexual satisfaction, interpersonal relationships, and the quality of life at large. An innovative formulation of Levitra ODT has been developed that enables men to more effectively control their sexual activity. The new preparation ensures the maximum comfortable intake and high functional effectiveness.

Keywords:

Levitra ODT

vardenafil

erectile dysfunction

safety

Authors:

Vertkin A.L.

Moskovskiĭ gosudarstvennyĭ mediko-stomatologicheskiĭ universitet

Morgunov L.Iu.

Moskovskiĭ gosudarstvennyĭ mediko-stomatologicheskiĭ universitet

List of references:

McKinlay J.B. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res 2000; 12: Suppl 4: S6-S11.
Montorsi F., Adaikan G., Becher E. Summary of the recommendations on sexual dysfunctions in men. J Sex Med 2010; 7: 11: 3572-3588.
Satis FACTS. Mezhdunarodnyi opros. Baier KhelsKer 2011.
Perelman M., Edwards D. Perceptions of Erectile Dysfunction Therapy and Acceptance of an Orodispersible Phosphodiesterase Type 5 Drug Formulation Among Patients and Physicians. J Mens Health 2010; 7: 3: 325.
Fu Y., Yang S., Jeong S.H., Kimura S., Park K. Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies. Crit Rev Ther Drug Carrier Syst 2004; 21: 6: 433-476.
Leonardi R., Alemanni M. The management of erectile dysfunction: innovations and future perspectives. Arch Ital Urol Androl 2011; 83: 1: 60-62.
Debruyne F.M., Gittelman M., Sperling H., Börner M., Beneke M. Time to onset of action of vardenafil: a retrospective analysis of the pivotal trials for the orodispersible and film-coated tablet formulations. J Sex Med 2011; 8: 10: 2912-2923.
Heinig R., Weimann B., Dietrich H., Böttcher M.F. Pharmacokinetics of a new orodispersible tablet formulation of vardenafil: results of three clinical trials. Clin Drug Invest 2011; 31: 1: 27-41.
Sperling H., Gittelman M., Norenberg C., Ulbrich E., Ewald S. Efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction in elderly men and those with underlying conditions: an integrated analysis of two pivotal trials. J Sex Med 2011; 8: 1: 261-271.
Green R., Hicks R.W. Orally disintegrating vardenafil tablets for the treatment of erectile dysfunction: efficacy, safety, and patient acceptability. Patient Prefer Adher 2011; 5: 181-185.
Sperling H., Debruyne F., Boermans A., Beneke M., Ulbrich E., Ewald S. The POTENT I randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction. J Sex Med 2010; 7: 4: Pt 1: 1497-1507.
Gittelman M., McMahon C.G., Rodríguez-Rivera J.A., Beneke M., Ulbrich E., Ewald S. The POTENT II randomised trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction. Int J Clin Pract 2010; 64: 5: 594-603.
Sanford M. Orodispersible vardenafil tablet. Drugs 2012; 72: 1: 87-98.

Close metadata